TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

Benzinga Newsdesk www.benzinga.com Negative 74.9%

Neg 74.9% Neu 0% Pos 0%

TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $34 to $28.